云南高校图书馆联盟文献共享服务平台- Advances in Lung Cancer

检索规则说明：AND代表“并且”；OR代表“或者”；NOT代表“不包含”；(注意必须大写,运算符两边需空一格)

检索范例：范例一： (K=图书馆学 OR K=情报学) AND A=范并思　　　　范例二：J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual

全部期刊核心期刊 EI来源期刊 SCI来源期刊 CA来源期刊 CSCD来源期刊 CSSCI来源期刊

Epidemiology of EGFR Mutation in Adenocarcinoma NSCLC Patients in India: A Systematic Review and Meta-Analysis: 《Advances in Lung Cancer》2024年第1期1-21,共21页Ankita Jain Kumar Prabhash Venkatraman Radhakrishnan Shashank Srinivasan; Studies reporting the Indian prevalence of Epidermal Growth Factor Receptor (EGFR) mutation are mostly single centers with small sample sizes. This systematic review and meta-analysis summarized the available evidence...; 关键词：EPIDEMIOLOGY Epidermal Growth Factor Receptor ADENOCARCINOMA Non-Small Cell Lung Cancer INDIA

Association between the TP53 Arg72Pro Polymorphisms and Gastric Cancer Risk: An Updated Meta-Analysis and Re-Analysis of Systematic Meta-Analyses: 《Advances in Lung Cancer》2023年第1期1-19,共19页Lili Huo Yuwei Wang Di Wang Jingyi Chen Changqing Yang Xiaofeng He; Background: A latest Meta-analysis on TP53 Arg72Pro polymorphism with gastric cancer (GC) risk was published in 2015 including 20 literatures, while our study included 43 studies. Moreover, the results of previously p...; 关键词：P53 Polymorphism Gastric Cancer META-ANALYSIS BFDP FPRP

Targeting TIGIT in NSCLC—Is There Light on the Horizon?: 《Advances in Lung Cancer》2022年第4期51-60,共10页Susanne Reuther Wolfram C. M. Dempke; Non-small cell lung cancers (NSCLCs) represent over 80% of all malignant lung tumours and are one of the leading causes of cancer death throughout the world. First- and second-line treatment of advanced or metastatic ...; 关键词：NSCLC TIGIT SKYSCRAPER Trials KEYVIVE Studies Domvanalimab Ociperlimab

Immunotherapy in Early Stage Non-Small Cell Lung Cancer: 《Advances in Lung Cancer》2022年第3期31-44,共14页Jeyanthi Ramanarayanan Ganapathy Krishnan; Immune-checkpoint inhibitors are extensively used in cancer treatment and have transformed the therapeutic landscape by inducing durable responses. Immunotherapy with checkpoint inhibitors targeting programmed death 1...; 关键词：Non-Small Cell Lung Cancer IMMUNOTHERAPY Immune Checkpoint Inhibitors ADJUVANT NEOADJUVANT Early Stage

Application Problems and Countermeasures of External Diaphragm Pacer in Elderly Patients with Lung Cancer after Surgery: 《Advances in Lung Cancer》2022年第3期45-50,共6页Chuanzhen Li Linjuan Zeng Shiwen Zhang Jiudi Zhong; This article summarized the nursing problems and corresponding nursing strategies of 18 cases of external diaphragm pacemakers in the application of elderly patients with lung cancer after thoracic surgery. Timely psy...; 关键词：External Diaphragm Pacemaker Pulmonary Rehabilitation Lung Cancer Sur-gery Nursing Problems COUNTERMEASURES

Association between the DNA Repair Gene Polymorphisms and Lung Cancer in Turkish Population: 《Advances in Lung Cancer》2022年第2期15-29,共15页Nuran Dingil Ziyaeddin Inan Ayşegül Şentürk; Introduction: DNA repair enzymes continuously monitor DNA to correct damaged nucleotide residues generated by exposure to environmental mutagenic and cytotoxic compounds or carcinogens. Our objective was to investigat...; 关键词：Lung Cancer POLYMORPHISM DNA Repair Genes Turkish Population PCR-RFLP

C-MET Inhibitors as New Members of the NSCLC Treatment Armamentarium—A Pooled Analysis: 《Advances in Lung Cancer》2022年第1期1-13,共13页Susanne Reuther Niccolo Bassani Michael F. Murphy Wolfram Dempke; Objective: Capmatinib and tepotinib, two recently FDA-approved and highly specific small-molecule inhibitors of c-MET exon 14 skipping mutations are new and important therapeutic options for the treatment of NSCLC pat...; 关键词：NSCLC Treatment Options c-MET Inhibitors Statistical Analysis

Study on the Changes of Immune Factors in Different Stages of Non-Small Cell Lung Cancer Chemotherapy被引量：1: 《Advances in Lung Cancer》2021年第4期57-64,共8页Jingjing Zhang Dianbin Song Yi Dong Lu Bai Dongqi Gao Yan Guo Fubo Li Xiaolei Yu Shenglin Zhang; Objective: To analyze various immune cytokines (NKG2D, IL-12, IL-15, IL-18, DC cells, TNF-a, IFN-r) and peripheral blood of patients with non-small cell lung cancer (NSCLC) at different times after ch...; 关键词：Non-Small Cell Lung Cancer Chemotherapy NKG2D IL-12 IL-15 IL-18 DC Cells TNF-A IFN-R Immune Cytokines

Three Novel Autophagy-Related lncRNAs as Prognostic Biomarkers for Lung Adenocarcinoma: 《Advances in Lung Cancer》2021年第4期65-77,共13页Zhi-Peng Miao Lei Liu Dong-Juan Wang Cai-Ling Jiang Cui-Min Zhu Hua-Chuan Zheng Li Zhang; Background: In the present study, autophagy-related long non-coding RNAs (lncRNAs) in lung adenocarcinoma (LUAD) were screened for diagnosis and prognosis, and the molecular mechanisms of LUAD at the ...; 关键词：Lung Adenocarcinoma lncRNA Prognostic Model AUTOPHAGY AC011477.2 AC099850.3 TRG-AS1

Molecular Therapeutics of Non-Small Cell Lung Cancer (NSCLC) and Challenges in Repeat Tissue Biopsy: 《Advances in Lung Cancer》2021年第3期21-39,共19页Devanna Vasista Ganesha Radheshyam Naik Suhail Sayeed Mufti Hrishi Varayathu; With advances in targeted and personalized treatment for lung cancer, molecular analysis of tumors is routinely performed for sequencing of treatment options in patients with advanced non-small-cell lung cancer (NSCLC...; 关键词：Liquid Biopsy Re-Biopsy CTDNA Driver Mutations

《Advances in Lung Cancer》